P
Phuong-Hien Nguyen
Researcher at University of Cologne
Publications - 16
Citations - 232
Phuong-Hien Nguyen is an academic researcher from University of Cologne. The author has contributed to research in topics: Chronic lymphocytic leukemia & LYN. The author has an hindex of 4, co-authored 9 publications receiving 174 citations.
Papers
More filters
Journal ArticleDOI
Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor
Nina Reinart,Phuong-Hien Nguyen,Jorge Boucas,Natascha Rosen,Hans-Michael Kvasnicka,Lukas C. Heukamp,Cornelia Rudolph,Vangica Ristovska,Tanja Velmans,Carolin Mueller,Katrin S. Reiners,Elke Pogge von Strandmann,Günter Krause,Manuel Montesinos-Rongen,Brigitte Schlegelberger,Marco Herling,Michael Hallek,Günter Fingerle-Rowson +17 more
TL;DR: Targeted deletion of the gene for macrophage migration inhibitory factor delays development of chronic lymphocytic leukemia and prolongs survival in mice and provides evidence that MIF supports the development of CLL by enhancing the interaction of Coll cells with macrophages.
Journal ArticleDOI
LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia
Phuong-Hien Nguyen,Oleg Fedorchenko,Natascha Rosen,Maximilian Koch,Romy Barthel,Tomasz Winarski,Alexandra Florin,F. Thomas Wunderlich,Nina Reinart,Michael Hallek +9 more
TL;DR: It is demonstrated that LYN kinase is essential for CLL progression and syngeneic CLL transplantation of CLL cells into Lyn- or Btk-deficient recipients results in a strongly delayed leukemic progression and prolonged survival.
Journal ArticleDOI
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia.
Gero Knittel,Tim Rehkämper,Darya Korovkina,Paul Liedgens,Christian Fritz,Alessandro Torgovnick,Yussor Al-Baldawi,Mona Al-Maarri,Yupeng Cun,Oleg Fedorchenko,Arina Riabinska,Filippo Beleggia,Phuong-Hien Nguyen,F. Thomas Wunderlich,Monika Ortmann,Manuel Montesinos-Rongen,Eugen Tausch,Stephan Stilgenbauer,Lukas P. Frenzel,Marco Herling,Carmen D. Herling,Jasmin Bahlo,Michael Hallek,Martin Peifer,Reinhard Buettner,Thorsten Persigehl,H. Christian Reinhardt +26 more
TL;DR: Two aggressive CLL models are generated and the authors provide a preclinical rational for the use of PARP inhibitors in ATM-affected human CLL and show that Atm-deficient CLL is sensitive to PARP1 inhibition.
Journal ArticleDOI
New roles for B cell receptor associated kinases: when the B cell is not the target.
TL;DR: The evidence for BAK inhibitors being part of a class of agents that modulate the (hematopoietic) microenvironment of cancers is summarized and validates.
Journal ArticleDOI
In Vitro Validation of the Therapeutic Potential of Dendrimer-Based Nanoformulations against Tumor Stem Cells
Nadezhda Knauer,V. N. Arkhipova,Guanzhang Li,Michael Hewera,Ekaterina Pashkina,Phuong-Hien Nguyen,Mariya I. Meschaninova,Vladimir A. Kozlov,Wei Zhang,Roland S. Croner,Anne-Marie Caminade,Jean-Pierre Majoral,Evgeny K. Apartsin,Ulf Dietrich Kahlert +13 more
TL;DR: The validation of the polycationic phosphorus dendrimer-based approach for small interfering RNAs delivery in in vitro stem-like cells as models shows that anti-Lyn siRNA, delivered into Lyn-expressing glioma cell model reduces the cell viability, a fact that was not observed in a cell model that lacks Lyn-expression.